Tymko MM, Ainslie PN, MacLeod DB, Willie CK, Foster GE. End tidal-to-arterial CO 2 and O2 gas gradients at low-and high-altitude during dynamic end-tidal forcing. Am J Physiol Regul Integr Comp Physiol 308: R895-R906, 2015. First published March 25, 2015 doi:10.1152/ajpregu.00425.2014.-We sought to characterize and quantify the performance of a portable dynamic end-tidal forcing (DEF) system in controlling the partial pressure of arterial CO 2 (PaCO 2 ) and O2 (PaO 2 ) at low (LA; 344 m) and high altitude (HA; 5,050 m) during an isooxic CO 2 test and an isocapnic O2 test, which is commonly used to measure ventilatory and vascular reactivity in humans (n ϭ 9). The isooxic CO 2 tests involved step changes in the partial pressure of end-tidal CO 2 (PETCO 2 ) of Ϫ10, Ϫ5, 0, ϩ5, and ϩ10 mmHg from baseline. The isocapnic O 2 test consisted of a 10-min hypoxic step (PET O 2 ϭ 47 mmHg) from baseline at LA and a 5-min euoxic step (PET O 2 ϭ 100 mmHg) from baseline at HA. At both altitudes, PET O 2 and PETCO 2 were controlled within narrow limits (Ͻ1 mmHg from target) during each protocol. During the isooxic CO 2 test at LA, PETCO 2 consistently overestimated PaCO 2 (P Ͻ 0.01) at both baseline (2.1 Ϯ 0.5 mmHg) and hypercapnia (ϩ5 mmHg: 2.1 Ϯ 0.7 mmHg; ϩ10 mmHg: 1.9 Ϯ 0.5 mmHg). This P a-PETCO 2 gradient was approximately twofold greater at HA (P Ͻ 0.05). At baseline at both altitudes, PET O 2 overestimated PaO 2 by a similar extent (LA: 6.9 Ϯ 2.1 mmHg; HA: 4.5 Ϯ 0.9 mmHg; both P Ͻ 0.001). This overestimation persisted during isocapnic hypoxia at LA (6.9 Ϯ 0.6 mmHg) and during isocapnic euoxia at HA (3.8 Ϯ 1.2 mmHg).
Several different DEF systems have been developed over the past few decades, each with their own strengths and weaknesses (21, 36, 39, 42) . Most recently, a compact portable DEF system by Koehle et al. (21) has been developed. This system is portable and involves filling medical grade CO 2 , N 2 , and "air" into a reservoir bag by the time-dependent control of three gas solenoid valves (one for each mixing component). Similar to this DEF system (21), we recently developed a DEF system capable of controlling end-tidal gases while being portable. This system uses a mixture of three gases (O 2 , CO 2 , and N 2 ) to deliver the desired inspiratory gas volume into a 6-liter capacity reservoir bag. This DEF system has effectively controlled end-tidal gases independent of breathing frequency during isocapnic and poikilocapnic hypoxia (14, 32) and during a hyperthermic intervention to correct marked hypocapnia (1) .
A common pitfall with DEF systems, first recognized by Swanson and Bellville (42) , is the assumption that end-tidal gas partial pressures accurately represent arterial blood gas pressures in all conditions (arterial blood gases being the stimulus for changes in vascular tone and chemoreflex activity). However, even in otherwise healthy individuals, there is a gradient between end-tidal and arterial blood gases likely due to a combination of dead space mixing (alveolar and anatomical), ventilation-perfusion (V /Q ) mismatching, and diffusion limitation, intrapulmonary and intracardiac shunting (11, 24, 41) . The end tidal-to-arterial PCO 2 gradient (P a -PET CO 2 ) is usually positive but can be altered with body position (4) and age (27) . Moreover, in some cases this gradient can be negative (i.e., PET CO 2 Ͼ Pa CO 2 ) with exercise (18) and low breathing frequencies (17) . Caution has been advised by Robbins et al. (35) when interpreting PET CO 2 during hypercapnic conditions with DEF, because administered CO 2 occupies physiological dead space during inspiration and mixes with alveolar gas during expiration, inflating PET CO 2 to a greater extent than Pa CO 2 (17, 35) . The same effect can be observed with increases in apparatus dead space (12) . There is a vast amount of literature reporting CO 2 gradients clinically and during experimental chemosensitivity testing (6, 47, 50) , and predictive correction equations for the end tidal-to-arterial gradient have been previously derived to accurately predict Pa CO 2 during exercise and with fixed fraction inspirate but not DEF (18, 29) . In contrast, there are few reports on the end tidal-to-arterial PO 2 gradient (P ET -Pa O 2 ; calculated as PET O 2 Ϫ Pa O 2 ) in the context of chemoreflex or vascular (e.g., cardiac, pulmonary, cerebral, etc.) testing during DEF. It is well established that the alveolarto-arterial difference is greater for O 2 compared with CO 2 . This means that end-tidal gas may not reflect Pa O 2 accurately in contrast to Pa CO 2 (40) . Chemosensitivity and vascular function tests often manipulate O 2 to low levels (hypoxia) and could be potentially harmful in individuals with abnormally large P ETPa O 2 gradients.
Because of the compact nature of our DEF system, it was used on a high-altitude (HA) research expedition to 5,050 m (barometric pressure ϳ413 mmHg). However, it is unknown how well end-tidal gases reflect arterial blood gases at extreme HA during DEF, which is extremely important because of recent innovations in DEF systems making them more portable for HA physiology research. The strong humoral response of hypoxia elicits several physiological adaptations, including heterogeneous hypoxic pulmonary vasoconstriction (46) , resulting in an increase in V /Q in some areas of the lung, which has been previously shown to increase physiological dead space (22) . In addition, because of HA-associated increases in chemosensitivity, a higher FI CO 2 and lower FI O 2 would be required to maintain PET CO 2 and PET O 2 during DEF (9, 37) . The implications of a heightened ventilatory sensitivity means that higher CO 2 and O 2 concentrations will occupy physiological dead space at HA, potentially altering the end tidal-to-arterial gas gradients.
The purpose of the present study was to quantify the end tidal-to-arterial gas gradient for both CO 2 and O 2 at LA and HA using a portable DEF system during 1) an isooxic CO 2 protocol and 2) an isocapnic O 2 protocol. To our knowledge, end-tidal gas control systems have not been used above 4,300 m, and end tidal-to-arterial gas gradients have not been directly measured during DEF at or above 5,050 m (28). We hypothesized that PET CO 2 would overestimate Pa CO 2 to a greater extent during a CO 2 protocol at HA, whereas PET O 2 would overestimate Pa O 2 at a lesser extent at HA due to a reduction in the arterial-venous gas gradient.
MATERIALS AND METHODS

Ethical Approval
All experimental procedures and protocols were approved by the clinical research ethics board at the University of British Columbia and the Nepal Health Medical Research Council and conformed to the Declaration of Helsinki. All participants provided written informed consent before participation in this study. This study was part of a larger research expedition conducted in April-June in 2012 (14, 23) . As such, participants took part in a number of studies conducted in Kelowna, BC and during 3 wk at the Ev-K2 CNR Pyramid Laboratory located near Mt. Everest basecamp at 5,050 m.
Participants
To assess pulmonary and cardiovascular health, altitude-naïve participants (n ϭ 12) were initially screened at LA (elevation ϭ 344 m, Kelowna, BC) for normal pulmonary function (FEV 1/FVC Ͼ 0.75), normal resting blood pressure (systolic blood pressure Ͻ140 and diastolic blood pressure Ͻ90 mmHg), and were required to fill out a medical history questionnaire. Three of these subjects were unable to participate in the HA protocols due to time constraints and one case of appendicitis; these subjects were excluded from our mean data analysis. Participants (n ϭ 9; all male) included in mean data analysis were nonsmokers; had no previous history of cardiovascular, cerebrovascular, or respiratory diseases; were not taking any medications during testing; and had an age (means Ϯ SE) of 32.0 Ϯ 1.9 yr, height of 180.0 Ϯ 1.1 cm, weight of 81.9 Ϯ 3.7 kg, and body mass index of 25.3 Ϯ 1.6 kg/m 2 . All participants took acetazolamide (125 mg, 3ϫ day) during the trek to HA to minimize the risk of acute mountain sickness but medication was discontinued 24 h before ascending from Pheriche (4,300 m) to the Pyramid lab, which was at least 5 days before experimentation. The 8-to 10-day ascent profile to 5,050 m has been described in detail elsewhere (14, 23, 48) .
Respiratory Measurements
All respiratory parameters were acquired at 200 Hz using an analog-to-digital converter (Powerlab/16SP ML 880; ADInstruments, Colorado Springs, CO) interfaced with a personal computer. Commercially available software was used to analyze ventilatory and cardiovascular variables (LabChart V7.1, ADInstruments). Throughout all procedures, subjects breathed through a mouthpiece (with nose clip), a bacteriological filter, and a two-way nonrebreathing valve (7900 series, Hans Rudolph, Shawnee, KS). The resistance to airflow for this breathing apparatus is 0.80 and 0.73 cmH 2O·l
Ϫ1 ·s Ϫ1 at flow rates of 1.5 and 3.0 l/s, respectively. Respired gas pressures were sampled at the mouth, dried with nafion tubing, and analyzed for PET O 2 and PETCO 2 (ML206; ADinstruments). Gas analyzers were calibrated before each experiment with gases of known concentration using the same sample line used in the experiment. Measured PO2 and PCO2 were time corrected for gas analyzer sample delay, and the values corresponding to the end of expiration (i.e., when respiratory flow crossed zero in the positive to negative direction) were identified as the PET O 2 and PETCO 2 . FICO 2 and FIO 2 delivered to the subject for each breath were determined by our DEF system (see below) and recorded in a text file for subsequent analysis. Respiratory flow was measured near the mouth using a pneumotachograph (HR 800L, Hans Rudolph) and a differential pressure amplifier (ML141, ADinstruments), which was calibrated with a 3-liter syringe at a variety of expected flow rates. Total apparatus dead space was measured at 250 ml.
End-Tidal Forcing
The PET O 2 and PETCO 2 were controlled by a portable DEF system. This system uses independent gas solenoid valves for O2, CO2, and N2 and controls the volume of each gas being delivered to the inspiratory reservoir through a mixing and humidification chamber. PETO 2 , PETCO 2 , tidal volume (VT), breathing frequency (FB), and minute ventilation (V E) was determined for each breath online using specifically designed software (Labview 13.0, National Instruments, Austin, TX). With the use of feedback information regarding PET O 2 , PETCO 2 , inspired VT, and expired VT, the DEF system adjusts the inspirate to bring end-tidal gas to the desired target values. Feed-forward control of the inspirate is based on estimates of baseline metabolic O 2 consumption and CO2 production and employs the alveolar gas equation to determine the required FICO 2 and FIO 2 . Whereas feedback control is accomplished using a proportional and integral error reduction control system. This system has been used previously to control end-tidal gases during physiological stressors (1, 14, 32) . End-tidal steady state was determined once values were within 1 mmHg of the desired target point for at least three consecutive breaths.
Arterial Blood Sampling
After local anesthesia (2% lidocaine), a 20-gauge catheter (radial artery catheter, Arrow International, Reading, PA) was placed transcutaneously into the radial artery using ultrasound guidance and a modified Seldinger technique. The catheter was connected to a commercially available arterial blood sampling kit (VAMP Adult, Edwards Lifescience, Irvine, CA), allowing for repeated sampling and flushing with 0.9% saline. Before sampling was started, the dead space volume was withdrawn and then an arterial sample (3 ml) was collected in preheparanized syringes (safePICO syringes, Radiometer, Copenhagen, Denmark). Air bubbles were immediately evacuated from the syringe, and blood gas analysis was performed within 30 s of sampling with a gas analyzer (ABL90 FLEX, Radiometer). The blood gas analyzer was calibrated every 8 h using manufacturer's standard internal quality checks, and external ampule-based quality checks were routinely performed to confirm internal calibrations. Reported variables that were calibrated and analyzed included Pa O 2 , PaCO 2 , and arterial oxyhemoglobin (SaO 2 ). After cannulation, all subjects rested quietly in a supine position breathing room air for at least 30 min to ensure normal baseline measurements before beginning the experimental protocol.
Experimental Design
This study was conducted in two parts: LA and HA investigations. Before each experiment, all participants abstained from exercise and alcohol for 24 h and caffeine for 12 h. All testing was conducted while participants lay in supine position. Baseline measurements are made during the last 2 min of a 5-min period of eupnea breathing room air.
Low-altitude protocols (344 m). LA studies involved both CO 2-LA and O2-LA protocols. A minimum of 15 min separated each protocol, and protocols were not randomized (CO2 protocol completed first) to avoid any confounds involving carry-over effects of sympathetic nervous activity associated with exposure to acute hypoxia (49) .
PROTOCOL CO2-LA. This protocol was selected because it can be used to assess the ventilatory and cerebral vascular response to CO2 (47) . PETO 2 was controlled immediately after baseline at 100 mmHg for the duration of the protocol. After 5 min of baseline, an arterial blood gas sample was collected and then PETCO 2 was altered and controlled in a stepwise fashion at Ϫ10, Ϫ5, 0, ϩ5, ϩ10, and ϩ15 mmHg from individual baseline values. Targeted PETCO 2 in the hypocapnic range was achieved through active hyperventilation and controlled by the DEF system. Each step change in PETCO 2 lasted for ϳ3 min after steady state was reached, and an arterial blood sample was carefully collected during the final 30 s of each stage.
PROTOCOL O2-LA. This protocol was selected because it is often used to determine both the ventilatory and vascular responses to isocapnic hypoxia (46, 47) . In this protocol, PETCO 2 was controlled at ϩ1 mmHg above baseline values for the entire duration of the protocol except for baseline. After 5 min of baseline, an arterial blood sample was collected and then PET O 2 was decreased to 47 mmHg. This value (PETO 2 ϭ 47 mmHg) was selected based on previous research at the same location showing that subjects on average have a baseline PETO 2 of 47 mmHg at 5,050 m and this facilitated a comparison to the baseline state in the HA condition (13) . After PETO 2 reached its target value (time ϭ 0 min), arterial blood samples were collected at 7 and 10 min.
High-altitude protocols. HA studies involved DEF protocols for CO 2 and to hypoxia relief (protocols CO2-HA and O2-HA, respectively). A minimum of 15 min separated each protocol with the CO2 protocol conducted first.
PROTOCOL CO2-HA. Similar to protocol CO2-LA, CO2-HA was used to investigate cerebral vascular and chemoreflex sensitivity to step changes in CO 2. PETO 2 was controlled at baseline values for the entire duration of the protocol (46.8 Ϯ 1.0 mmHg). After a 5-min baseline, an arterial blood sample was collected and then PETCO 2 was controlled in a step-wise fashion at Ϫ10, Ϫ5, 0, ϩ5, and ϩ10 mmHg from baseline values. Targeted PET CO 2 in the hypocapnic range was achieved through active hyperventilation and controlled by the DEF system. Because of heightened chemosensitivity at HA, a step change of ϩ15 mmHg PET CO 2 was too uncomfortable for most participants to endure and was therefore excluded from this protocol. Each step change in PETCO 2 lasted for 3 min after steady state was reached and an arterial blood sample was carefully collected during the final 30 s of each stage.
PROTOCOL O2-HA. O2-HA was used to address the changes in end-tidal to arterial gradient with the relief of environmental hypoxia. In this protocol, PETCO 2 was controlled at ϩ1 mmHg above baseline values during the entire protocol. In addition, to prevent the rise in PETCO 2 during hypoxia relief, subjects were asked to maintain slightly elevated and driven ventilation. After a 3-min baseline, an arterial blood sample was collected and then PET O 2 was controlled at 100 mmHg (relative hyperoxia). This value was selected to restore PET O 2 to LA values. After end-tidal gases were stable (time ϭ 0 min), arterial blood samples were collected at 4 and 5 min. The O 2 protocol was shorter at HA compared with LA to conserve limited gas supply at the field-based laboratory.
Statistical Analysis
To ensure an adequate power (Ͼ0.80) to detect a change in Pa-PETCO 2 gradient from rest to hypercapnia a sample size calculation was conducted based on the PETCO 2 and PaCO 2 values reported by Peebles et al. (29) . To increase our power of detection for the comparison of LA and HA parameters and to account for the possibility of subject illness and dropout at HA, the sample size was increased to n ϭ 12. All data were analyzed using SigmaStat V11.5 (Systat, Chicago, IL). For each protocol baseline measurements were averaged over 2 min immediately before the start of the test.
During the CO 2 protocols (CO2-LA and CO2-HA), all measurements were averaged over a 1-min period at the end of each CO2 stage, just before arterial blood sampling. During the O2 protocols (O2-LA and O2-HA), all measurements were averaged 1 min before minutes 7 and 10 at LA, and at minutes 4 and 5 at HA, in association with when the arterial blood samples were collected. These two measurements, taken near the end of the O 2 protocol for both LA and HA, were subsequently averaged together.
Two-way (altitude: LA vs. HA ϫ PETCO 2 step: Ϫ10, Ϫ5, 0, ϩ5, ϩ10) repeated measures analysis of variance (RM ANOVA) was used to compare differences (P Ͻ 0.05) in respiratory, cardiovascular, and arterial blood measurements between LA and HA for CO 2 tests. One-way (PETCO 2 step: Ϫ10, Ϫ5, 0, ϩ5, ϩ10, ϩ15) RM ANOVA was used to compare differences (P Ͻ 0.05) in respiratory, cardiovascular, and arterial blood measurements within LA data during the CO 2 test, as the additional ϩ15 mmHg PETCO 2 step at LA hindered comparisons to HA. When significant F ratios were detected, post hoc comparisons within LA and HA were made using Tukey's HSD. Paired t-tests were used to determine 1) differences between LA and HA for all outcome measures during the CO 2 tests, 2) differences between end-tidal gases and arterial blood gases for both CO2 and O2 tests within LA and HA, and 3) differences between baseline and O2 condition within LA (isocapnic hypoxia) and HA (isocapnic euoxia). Bland-Altman plots were used to assess the agreement between end-tidal and arterial blood gases. The 95% limits of agreement were calculated by using Ϯ 1.96 ϫ SD of the bias (8) . Multiple forward stepwise regression analysis was used to determine which variables could accurately predict arterial blood gases. For each condition, regression equations were determined for both Pa CO 2 and PaO 2 as the dependent variable. The following independent variables were included in the regression analysis: V E, VT, FB, FIO 2 , FICO 2 , PETO 2 , PETCO 2 , and the baseline PET-PaO 2 and Pa-PETCO 2 gradient. P Ͻ 0.05 was used to determine the tolerance for including independent variables in the regression model. All data are expressed as mean values Ϯ SE. Table 1 displays ventilatory data for the isooxic CO 2 test at both LA and HA. As expected, V E, V T , and F B were elevated compared with baseline throughout hypocapnia (Ϫ10 and Ϫ5 mmHg PET CO 2 step) and hypercapnia (ϩ5, ϩ10, and ϩ15 mmHg PET CO 2 step) ranges. FI CO 2 was elevated, while FI O 2 was decreased from baseline in both hypo-and hypercapnic ranges (P Ͻ 0.05). The average difference between measured PET CO 2 and target PET CO 2 (target PET CO 2 ϭ Ϫ10, Ϫ5, 0, ϩ5, ϩ10, and ϩ15 mmHg from baseline) was 0.6 Ϯ 0.3 mmHg, and the difference between measured PET O 2 and target PET O 2 (target PET O 2 ϭ 100 mmHg) was Ϫ0.2 Ϯ 0.1 mmHg throughout the protocol. Table 2 displays end-tidal and arterial blood gas values at baseline and during the isooxic CO 2 test at both LA and HA. At LA, significant (P Ͻ 0.01) P a -PET CO 2 gradients were present at baseline, ϩ5 mmHg, and ϩ10 mmHg PET CO 2 steps. Multiple stepwise regression analysis determined that PET CO 2 (P Ͻ 0.001) and the P a -PET CO 2 gradient at baseline (P ϭ 0.08) were the best predictors of Pa CO 2 during DEF at LA. Linear regression analysis identified the following equations for accurately predicting Pa CO 2 :
RESULTS
CO 2 -LA Test
We found that there was a P ET -Pa O 2 gradient at LA baseline (P Ͻ 0.001) and ϩ15 mmHg (P ϭ 0.02) PET CO 2 step (see Table  2 ). The P ET -Pa O 2 gradient was reduced during DEF (i.e., during the PET CO 2 steps) compared with the uncontrolled baseline ( Table 2 ; P Ͻ 0.001). Based on these findings it was deemed unnecessary to correct for the P ET -Pa O 2 gradient during the CO 2 test at LA.
CO 2 -HA Test
As illustrated in Table 1 , V E and F B were significantly elevated compared with baseline throughout both hypocapnic (Ϫ10 and Ϫ5 mmHg PET CO 2 steps) and hypercapnic (ϩ5 and ϩ10 mmHg PET CO 2 steps) ranges. V T remained unchanged during the hypocapnic range but was significantly increased during hypercapnia. FI CO 2 was elevated from baseline at each PET CO 2 step with the exception of Ϫ10 mmHg, whereas FI O 2 was decreased from baseline in both hypo-and hypercapnic ranges (P Ͻ 0.05). The average difference between measured PET CO 2 and target PET CO 2 (PET CO 2 ϭ Ϫ10, Ϫ5, 0, ϩ5, and ϩ10 mmHg from baseline) was 0.4 Ϯ 0.2 mmHg, and the difference between measured PET O 2 and target PET O 2 (target PET O 2 ϭ 46.8 mmHg) was 0.1 Ϯ 0.3 mmHg throughout the protocol. Displayed in Table 2 , we found that there was a P a -PET CO 2 gradient (P Ͻ 0.01) not only at baseline but also during each stage of hypocapnia and hypercapnia. In addition, throughout the CO 2 protocol the P a -PET CO 2 gradient was significantly greater (i.e., more negative) during the hypercapnic steps compared with the hypocapnic steps (P Ͻ 0.05). Multiple stepwise regression analysis determined that PET CO 2 (P Ͻ 0.001) and the baseline P a -PET CO 2 gradient (P Ͻ 0.001) were the best predictors of Pa CO 2 when using DEF at HA. With the use of linear regression analysis including these variables, the following equations were derived which accurately predict Pa CO 2 :
We also found that there was a P ET -Pa O 2 gradient present during baseline (P Ͻ 0.001) and all stages of hypocapnia (P Ͻ 0.01) and hypercapnia (P Ͻ 0.001), as seen in Table 2 . This gradient remained unchanged from baseline throughout the CO 2 protocol meaning that the P ET -Pa O 2 gradient can be corrected for during the CO 2 protocol using the individual's baseline P ET -Pa O 2 gradient (P Ͻ 0.001). Reported P values represent differences between low-altitude (LA) and high-altitude(HA). *P Ͻ 0.05 vs. baseline. †P Ͻ 0.05 LA vs. HA. P values for the main effects of end tidal-to-arterial gas gradient of CO2 (PETCO 2 ) step and altitude, and the P value of the interaction effect are displayed above each measured variable.
Comparison of CO 2 -LA and CO 2 -HA Tests
Differences between HA and LA for respiratory and arterial blood gases are reported in Tables 1 and 2 . Breathing frequency was significantly elevated at HA compared with LA during baseline, hypocapnia, and hypercapnia. V E and V T were unchanged at baseline and during active hyperventilation between LA and HA but were higher at HA during hypercapnia. The FI CO 2 was significantly greater at HA compared with LA at Ϫ10 mmHg, ϩ5 mmHg, and ϩ10 mmHg (P Ͻ 0.05). The FI O 2 was unchanged between LA and HA in the hypocapnic range but was lower during HA in the hypercapnic range (P Ͻ 0.05). The P a -PET CO 2 gradient (P Ͻ 0.05) was significantly greater (i.e., more negative) at HA compared with LA at baseline, ϩ5, and ϩ10 PET CO 2 steps (see Table 2 , and Figs. 1 and 2 ). As mentioned, there was no P a -PET CO 2 gradient found during hypocapnia at LA nor did we achieve a ϩ15 mmHg PET CO 2 step at HA; thus, these comparisons were not made.
The P ET -Pa O 2 gradient (P Ͻ 0.05) was significantly greater (i.e., more positive) at HA compared with LA during DEF at Ϫ10, Ϫ5, ϩ5, and ϩ10 mmHg PET CO 2 steps (see Table 2 ). Table 3 displays ventilatory and arterial blood data during the isocapnic O 2 test at both LA and HA. V E, V T , and F B significantly increased from baseline during isocapnic hypoxia. We found that there was a P ET -Pa O 2 gradient at baseline (6.9 Ϯ 2.1 mmHg, P Ͻ 0.001) and during isocapnic hypoxia (6.9 Ϯ 0.6 mmHg, P Ͻ 0.001) (Fig. 3) . The average difference between measured PET O 2 and target PET O 2 (target PET O 2 ϭ 47 mmHg) was 0.1 Ϯ 0.2 mmHg, and the difference between measured PET CO 2 and target PET CO 2 (target PET CO 2 ϭ ϩ1 mmHg from baseline) was Ϫ0.4 Ϯ 0.3 mmHg throughout the protocol. The FI O 2 was lower during isocapnic hypoxia compared with baseline, whereas the FI CO 2 was higher during isocapnic hypoxia compared with baseline (P Ͻ 0.05). There was no difference of the P ET -Pa O 2 gradient between baseline and isocapnic hypoxia (see Table 3 
O 2 -LA Test
Whereas there was a P a -PET CO 2 gradient during the O 2 protocol at baseline (Ϫ2.0 Ϯ 0.4 mmHg, P Ͻ 0.001), this gradient was abolished during isocapnic hypoxia (Table 3) .
O 2 -HA Test
In Table 3 , V E and V T did not change from baseline after administration of isocapnic euoxia, but F B was elevated. The Values are means Ϯ SE. PETCO 2 , end-tidal partial pressure of CO2; PaCO 2 , arterial partial pressure of CO2; Pa-PETCO 2 , end tidal-to-arterial gas gradient of CO2; PETO 2 , end-tidal partial pressure of O2; PaO 2 , arterial partial pressure O2; PET-PaO 2 , end tidal-to-arterial gas gradient of O2. Reported P values represent differences between LA and HA (statistical significance set at P Ͻ 0.05). *P Ͻ 0.05, vs. baseline. †P Ͻ 0.05 LA vs. HA. ‡P Ͻ 0.05 end-tidal vs. arterial gases (i.e., significant gradient). §P Ͻ 0.05, Pa-PETCO 2 hypercapnia vs. hypocapnia (Ϫ10 and Ϫ5 mmHg) at HA. The P values for the main effects of PETCO 2 step and altitude, and the P value of the interaction effect are displayed above the three columns. difference between measured PET O 2 and target PET O 2 (target PET O 2 ϭ 100 mmHg) was Ϫ0.1 Ϯ 0.2 mmHg, and the difference between measured PET CO 2 and target PET CO 2 (target PET CO 2 ϭ 100 mmHg) was Ϫ0.5 Ϯ 0.3 mmHg from our target (target PET CO 2 ϭ ϩ1 mmHg from baseline) throughout the protocol.
Also shown in Table 3 , we found that there was a P ET -Pa O 2 gradient at baseline and during isocapnic euoxia (Fig. 4) . The FI O 2 and FI CO 2 were higher during isocapnic euoxia compared with baseline (P Ͻ 0.05). There was no difference in the P ET -Pa O 2 gradient between these conditions. Multiple step-wise regression 
In addition, we found that there was a P a -PET CO 2 gradient at baseline and isocapnic euoxia, as displayed in Table 3 . This gradient remained unchanged from baseline throughout the O 2 protocol meaning that Pa CO 2 can be accounted for based on the individual's P ET -Pa CO 2 gradient during the O 2 -HA protocol (P Ͻ 0.001).
Comparison of O 2 -LA and O 2 -HA Tests
There were no significant differences when comparing the P ET -Pa O 2 gradient between baseline at LA to isocapnic euoxia at HA (P ϭ 0.15) and between isocapnic hypoxia at LA to baseline at HA (P ϭ 0.08), where PET O 2 values were similar to one another. It was deemed unreasonable for the O 2 tests conducted at LA and HA to be directly compared with one another outside of baseline since the two tests were fundamentally different from one another and as a result we did not conduct any other statistical analysis between LA and HA.
DISCUSSION
The primary purpose of this study was to quantify the end tidal-to-arterial gradients for both O 2 and CO 2 at LA and, for the first time, HA during an isooxic CO 2 and an isocapnic O 2 protocol. The main findings from this study are the following: 1) the P a -PET CO 2 gradient is greater at HA (i.e., more negative) compared with LA, especially during hypercapnia; 2) the P ET -Pa O 2 gradient remained the same between LA and HA at baseline and was unchanged during isocapnic hypoxia (at LA) and relative hyperoxia (at HA); and 3) our recently developed computer-controlled portable DEF system effectively targets PET O 2 and PET CO 2 at both LA and HA. Based on the results from this study, correction equations were derived using multiple step-wise regression analysis. This approach was utilized to improve predictions of arterial blood gases at SL and HA during DEF.
A DEF System for Controlling End-Tidal Gases at LA and HA
Our DEF system has been previously used to control endtidal gases in other recent studies (1, 14, 32) , but its performance has not yet been formally quantified. This DEF system is inexpensive and portable making it possible to perform studies in remote HA environments as well as at LA. To our knowledge, this is the first study to use a computer-controlled DEF system above 5,000 m (28). On average this DEF system was able to control end-tidal gases within 1 mmHg from our target end-tidal values. In addition, there were no differences in the ability of our DEF system to target PET O 2 and PET CO 2 between LA and HA environments (see Figs. 1 and 4) .
Relationship Between PET CO 2 and Pa CO 2 at LA and HA
There are a number of reported conditions where PET CO 2 does not accurately reflect Pa CO 2 such as exercise, aging, body position, and in patients with abnormal lung conditions such as pulmonary oedema and pneumonia (4, 18, 25, 27, 31) . In contrast to some previously reported data (7, 35) , our study found that there was a negative P a -PET CO 2 gradient at baseline similar to that reported by Peebles et al. (29) . Apparatus dead space could potentially explain our negative P a -PET CO 2 gradient at baseline, but perhaps a better explanation is that we found large negative P a -PET CO 2 gradients in three of our subjects at LA shifting our mean bias enough to become statistically significant. In addition, we found a negative P a -PET CO 2 during hypercapnia (ϩ5, and ϩ10 mmHg) at LA. No gradient presented itself in the ϩ15 mmHg PET CO 2 step at LA; however, the P a -PET CO 2 gradient was close to significance (P ϭ 0.071). In contrast, at HA there was a P a -PET CO 2 gradient at baseline and during both hypocapnia and hypercapnia, and these gradients were of greater magnitude (i.e., more negative) compared with the gradients found at LA. The widening of the P a -PET CO 2 gradient between LA and HA could potentially be the result of a diffusion limitation from subclinical mild HA pulmonary oedema (44) . However, the participants in our study had no signs or symptoms of acute mountain sickness at the time of experimentation (experimentation took place between days 5 and 10 at HA). In addition, there was no change in the P ET-Pa O 2 gradient between LA and HA, which further supports the belief that diffusion limitation remains unchanged. The most likely explanation for the differences in the P a -PET CO 2 gradient between LA and HA is increased alveolar dead space (26, 44) . The P a -PET CO 2 gradient was not only greater at HA compared with LA, but it also widened progressively (i.e., became more negative) during hypercapnia at HA; this trend can be observed in Fig. 2 . One explanation for this phenomenon is the heightened ventilatory response at HA necessitates an increased FI CO 2 to maintain a given PET CO 2 during DEF, increasing the fraction of CO 2 trapped in physiological and apparatus dead space and thereby inflating the measured PET CO 2 . In addition to chronic hypoxia leading to an increase in alveolar dead space, there is also evidence demonstrating that administered PCO 2 can cause small airway dilation and pulmonary vasoconstriction augmenting the hypoxic pulmonary vasoconstriction response, potentially further increasing physiological dead space during hypercapnia, which could explain the P a -PET CO 2 gradient differences between hypocapnia and hypercapnia (2, 3, 20, 38) . A controversial mechanism suggested by Gurtner and Traystman (16) for negative gas gradients observed during steady-state hypercapnia is referred to as the "charged membrane hypothesis." Here, the suggested mechanism is that the generation of an electrical negative field near the capillary endothelial surface within the lung results in dissociation of weak acids and elevates local hydrogen ion concentration. The increase in local hydrogen ion concentration shifts the equilibrium of the bicarbonate-buffering relationship toward an increased PCO 2 (16) . However, this hypothesis is based on 1) anesthetized dogs during an extreme level of hypercapnia that is not tolerated by healthy humans, and 2) measured alveolar-to-arterial gradients in contrast to end tidal-to-arterial gradients. Therefore, we speculate that our observations are more likely due to an effect of physiological dead space on end-tidal gas sampling. During our isocapnic O 2 test, participants endured a hypoxic step change at LA and a euoxic step change at HA, while PET CO 2 was controlled at ϩ1 mmHg above baseline values. We discovered that there was a P a -PET CO 2 gradient at LA during our uncontrolled baseline period, but this gradient was abolished during isocapnic hypoxia. In contrast, at HA, there was a P a -PET CO 2 gradient of the same magnitude at baseline and during isocapnic euoxia. At baseline, PET CO 2 overestimated Pa CO 2 at HA to a greater degree compared with LA. Our data indicate that during an acute isocapnic hypoxia test at LA the P a -PET CO 2 gradient is negligible but is maintained during hypoxia (e.g., high-altitude, normobaric hypoxia).
Differences in PET O 2 and Pa O 2 at LA and HA
Surprisingly, there is little literature available with respect to the P ET -Pa O 2 gradient during DEF at LA or HA. Although experiments investigating the alveolar-to-arterial oxygen difference (AaDO 2 ) between LA and HA exist, it is difficult to assess the AaDO 2 during DEF necessitating the study of the P ET -Pa O 2 gradient in its place. However, literature regarding the AaDO 2 is inconsistent suggesting that the AaDO 2 can widen or narrow following ascent to HA at baseline (22, 33, 45) . During DEF, inspired gas concentrations are constantly changing making it difficult to assess alveolar PO 2 . The P ET -Pa O 2 gradient differs from the AaDO 2 because it includes some mixing of alveolar gas with physiological dead space gas.
During the isocapnic hypoxia test at LA, both baseline measures and measurements taken near the end of the protocol showed that PET O 2 consistently overestimated Pa O 2 , and these gradients measured at LA were unchanged from each other. Intuitively, the P ET -Pa O 2 gradient would increase with isocapnic hypoxia due to increased alveolar dead space from hypoxic pulmonary vasoconstriction; however, the hypoxic stimulus we administered (10 min) would have resulted in a modest change in pulmonary artery pressure compared with that at HA (15) .
The isocapnic O 2 protocol used at HA was fundamentally different from the one used at LA. The HA isocapnic O 2 test involved administering higher amounts of O 2 from baseline to values that were similar to those seen during baseline at LA (euoxia). For this reason we did not compare the P ET-Pa O 2 gradient between the LA and HA outside of our baseline measures, as we technically delivered different stimuli. The unchanged P ET -Pa O 2 gradient seen at baseline between LA and HA in healthy subjects was somewhat unexpected because there are likely HA-related changes in alveolar dead space volume. However, this is likely explained by the reduction in atmospheric PO 2 at HA, making the inspiratory PO 2 to Pa O 2 difference lower, which will minimize the difference between end-tidal and arterial PO 2 . The concomitant changes of alveolar dead space and the reduction of atmospheric PO 2 associated with HA may oppose each other in such a manner that the net result is an unchanged P ET -Pa O 2 gradient observed during baseline between LA and HA. Changes in alveolar dead space not only occur during hypoxia (acute and chronic), but it may also occur during hyperoxia (i.e., increased FI O 2 ) (50). During hyperoxia, there is a redistribution of pulmonary blood from poorly perfused alveoli to highly perfused alveoli due to pulmonary vasodilation potentially further increasing physiological dead space during hypercapnia (50) . The end result is an increase in alveolar dead space volume which has the potential of widening the P ET -Pa O 2 gradient. However, we did not observe this effect at HA, as the P ET -Pa O 2 gradient was unchanged between baseline and isocapnic euoxia (PET O 2 ϭ 100 mmHg). It is possible that our euoxia stimulus was not strong enough or applied for too short a time period to elicit a significant response.
Can Pa CO 2 be Predicted From PET CO 2 During End-Tidal Forcing?
Previous equations have been proposed for predicting Pa CO 2 by Jones et al. (18) during exercise and by Peebles et al. (29) during hypocapnia (through active hyperventilation) and hypercapnia (increased fixed FI CO 2 inspirate). However, as highlighted in Fig. 5 , we found that the correction algorithms proposed by Jones et al. (18) and Peebles et al. (29) could not accurately predict Pa CO 2 during our DEF protocols (likely because of the different experimental conditions); therefore, multiple stepwise regression analysis was used to determine which variables might predict Pa CO 2 at LA and HA. Based on these variables we conducted linear regression analysis with Pa CO 2 as our dependent variable to better predict Pa CO 2 at LA and HA. Our results suggest that a correction algorithm that includes PET CO 2 as a variable will more accurately predict Pa CO 2 .
Methodological Considerations
Acetazolamide (a carbonic anhydrase inhibitor) decreases the risk of high-altitude sickness by increasing central chemoreflex drive and improving arterial oxygenation (43) . Acetazolamide administration has been proven useful for safe acclimatization to extreme altitude and effectively reduces the risk of pulmonary edema (thus diffusion limitation) and alveolar dead space due to improved V /Q matching (44, 46) . Therefore, if acetazolamide had long-lasting effects (i.e., 5 days beyond its discontinuation), it could be argued that our results have underestimated the true difference in end tidal-toarterial gradient between LA and HA during DEF. This pos-sibility would seem unlikely, however, given the rapid clearance of acetazolamide (Ͻ36 h) (34) .
Despite the advantages of our DEF system being portable, cost effective (due to low gas requirements), and capable of controlling end-tidal gases within narrow limits, it, similar to other systems, is affected by methodological constraints. First, similar to all DEF systems, hypocapnic steps can only be achieved by asking participants to actively hyperventilate, driving their PET CO 2 below desired targets where the DEF is then capable of controlling and fine tuning PET CO 2 by adding CO 2 into the breathing circuit. Thus, with hypocapnia, endtidal gas control is dependent on the ability of the participant to maintain a constant rate of ventilation. Second, similar to the DEF system developed by Koehle et al. (21) , our DEF system functions by mixing inspirate into a reservoir bag on a breathby-breath basis. In an ideal world the reservoir bag would be emptied with each breath so that only the inspirate for the next breath is available to the subject at any given time. However, to deal with variation in V T with each breath, a small amount of extra air remains in the reservoir bag to prevent its complete emptying. This safety volume is normally 100 ml more than the current V T but can be adjusted by the DEF operator to maintain the reservoir volume as small as possible. In addition, the algorithm for the system estimates the volume of each gas remaining in the reservoir and takes these volumes into account before injecting the next volume of gases to better target the correct fractions of inspired O 2 and CO 2 . Nonetheless, inaccuracies in this prediction or inflation in the estimated reservoir volume can lead to a sluggish response or a delay in the systems response to a perturbation. Third, our DEF system uses 100% CO 2 , O 2 , and N 2 compressed gas to fill our inspirate reservoir. Although avoiding premixed gases is usually less expensive, it does present some potential safety issues as it is possible for the participant to be administered 100% N 2 during a severe hypoxic step. Therefore, it is crucial to employ a well-trained DEF device operator to recognize these potential issues. If a problem arises in which the participant's end-tidal values are not being controlled properly, 100% O 2 can be delivered to the participant for safety reasons. Finally, similar to all DEF system, our DEF system assumes the end-tidal gases are a surrogate for arterial blood gases.
Perspectives and Significance
We hypothesized that PET CO 2 would overestimate Pa CO 2 to a greater extent during a CO 2 protocol at HA, while PET O 2 would overestimate Pa O 2 to a lesser extent at HA due to a reduction in the arterial-venous gas gradient. In agreement with our hypothesis, we demonstrated that during DEF Pa CO 2 is systematically overestimated by PET CO 2 at baseline, hypocapnia, and hypercapnia at HA, but only at baseline and hypercapnia at LA. This overestimation of Pa CO 2 is exacerbated at HA compared with LA. In contrast to our hypothesis, we found that PET O 2 overestimates Pa CO 2 by the same magnitude at LA and HA, and these gradients remained unchanged throughout the O 2 protocols. The correction algorithms derived are specific to our experimental conditions including our study sample, altitude, the CO 2 and O 2 protocols employed, and possibly only our DEF system. However, these algorithms need to be validated in an independent sample during similar protocols. We recom- mend that the end tidal-to-arterial gas gradients be considered when performing common ventilatory and vascular reactivity protocols to CO 2 and O 2 as they could potentially effect the measured response. With future validation, it may be possible to use the regression equations reported here to estimate arterial blood gases in the event that invasive measurements are not feasible.
